Phillips BE - Search Results

1

A peptide-based material platform for displaying antibodies to engage T cells.

Zheng Y, Wen Y, George AM, Steinbach AM, Phillips BE, Giannoukakis N, Gawalt ES, Meng WS. Zheng Y, et al. Among authors: phillips be. Biomaterials. 2011 Jan;32(1):249-57. doi: 10.1016/j.biomaterials.2010.08.083. Epub 2010 Sep 28. Biomaterials. 2011. PMID: 20880580

2

A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes.

Phillips B, Nylander K, Harnaha J, Machen J, Lakomy R, Styche A, Gillis K, Brown L, Lafreniere D, Gallo M, Knox J, Hogeland K, Trucco M, Giannoukakis N. Phillips B, et al. Diabetes. 2008 Jun;57(6):1544-55. doi: 10.2337/db07-0507. Epub 2008 Mar 3. Diabetes. 2008. PMID: 18316361 Free PMC article.

3

Renal diseases as targets of gene therapy.

Phillips B, Giannoukakis N, Trucco M. Phillips B, et al. Contrib Nephrol. 2008;159:1-12. doi: 10.1159/000125552. Contrib Nephrol. 2008. PMID: 18391581

4

Toward a cure for type 1 diabetes mellitus: diabetes-suppressive dendritic cells and beyond.

Giannoukakis N, Phillips B, Trucco M. Giannoukakis N, et al. Pediatr Diabetes. 2008 Jun;9(3 Pt 2):4-13. doi: 10.1111/j.1399-5448.2008.00401.x. Pediatr Diabetes. 2008. PMID: 18540865

5

Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitus.

Phillips BE, Giannoukakis N, Trucco M. Phillips BE, et al. Pediatr Endocrinol Rev. 2008 Jun;5(4):873-9. Pediatr Endocrinol Rev. 2008. PMID: 18552749 Review.

6

Dendritic cell-based therapy in Type 1 diabetes mellitus.

Phillips B, Giannoukakis N, Trucco M. Phillips B, et al. Expert Rev Clin Immunol. 2009 May;5(3):325-39. doi: 10.1586/eci.09.8. Expert Rev Clin Immunol. 2009. PMID: 20477010

7

Identification of a cardiac specific protein transduction domain by in vivo biopanning using a M13 phage peptide display library in mice.

Zahid M, Phillips BE, Albers SM, Giannoukakis N, Watkins SC, Robbins PD. Zahid M, et al. Among authors: phillips be. PLoS One. 2010 Aug 17;5(8):e12252. doi: 10.1371/journal.pone.0012252. PLoS One. 2010. PMID: 20808875 Free PMC article.

8

Drug delivery technologies for autoimmune disease.

Phillips BE, Giannoukakis N. Phillips BE, et al. Expert Opin Drug Deliv. 2010 Nov;7(11):1279-89. doi: 10.1517/17425247.2010.527329. Epub 2010 Oct 20. Expert Opin Drug Deliv. 2010. PMID: 20958218 Review.

9

Interleukin-7 matures suppressive CD127(+) forkhead box P3 (FoxP3)(+) T cells into CD127(-) CD25(high) FoxP3(+) regulatory T cells.

Di Caro V, D'Anneo A, Phillips B, Engman C, Harnaha J, Lakomy R, Styche A, Trucco M, Giannoukakis N. Di Caro V, et al. Clin Exp Immunol. 2011 Jul;165(1):60-76. doi: 10.1111/j.1365-2249.2011.04334.x. Epub 2011 Mar 17. Clin Exp Immunol. 2011. PMID: 21413939 Free PMC article.

10

Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacity.

Di Caro V, D'Anneo A, Phillips B, Engman C, Harnaha J, Trucco M, Giannoukakis N. Di Caro V, et al. Immunol Res. 2011 Aug;50(2-3):130-52. doi: 10.1007/s12026-011-8206-1. Immunol Res. 2011. PMID: 21476100

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters